[ad_1]
According to Richard Bergström, the European Medicines Agency would recommend approval of Moderna’s vaccine only on Wednesday, but the scientific discussions have gone faster than expected.
– There is no reason to wait, he says and adds:
– The recommendation takes place on Monday morning and a couple of hours later it is formally approved by the European Commission.
First doses to Sweden in two weeks
Sweden has signed an agreement to purchase the Moderna vaccine, and under the agreement, the first doses must be delivered within two weeks of being approved by the EU.
– We will receive between 20,000 and 30,000 doses a week, says Richard Bergström.
The EU has previously approved the Pfizer / Biontech vaccine for delivery and in recent weeks between 80,000 and 90,000 doses per week have been delivered to Sweden, deliveries that Richard Bergström expects could be increased to 300,000 doses by the end of February as The Plant production plant in Marburg, Germany, receives a green light from the EU to start vaccine production.
“Signs of impatience”
In an interview with the German magazine Der Spiegel, Biontech CEO Ugur Sahin states that the availability of vaccines for the near future is threatened as the EU’s administrative processes drag on.
But, according to Richard Bergström, there is no risk of vaccine shortage.
– No no no. It’s rather the opposite, he says, adding that Ugur Sahin’s statement should be seen as a “sign of an impatient CEO,” as Biontech is waiting for the plant in Marburg to start, which will make the Pfizer / Biontech vaccine.
All adults vaccinated before summer
According to vaccine coordinator Richard Bergström, vaccine deliveries to Sweden and subsequent vaccination have so far gone according to plan. In February, the EU is also expected to approve the Astrazeneca vaccine, which means that Sweden will reach its vaccination targets.
– As it seems now, we will be able to vaccinate everyone in adulthood before summer, says Richard Bergström.
